Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Senseonics Holdings, Inc. (SENS : NSDQ)

• Company Description    Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. Number of Employees: 117

• Price / Volume Information    Yesterday's Closing Price: $5.89 Daily Weekly Monthly 20 Day Moving Average: 398,292 shares Shares Outstanding: 40.86 (millions) Market Capitalization: $240.66 (millions) Beta: 0.63 52 Week High: $8.73 52 Week Low: $0.41 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.48% -12.50% 12 Week -34.26% -35.45% Year To Date 6.70% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 20451 SENECA MEADOWS PARKWAY - GERMANTOWN,MD 20876 USA ph: 301-515-7260 fax: 301-515-0988 investors@senseonics.com http://www.senseonics.com

• General Corporate Information    Officers Timothy T. Goodnow - President; Chief Executive Officer and Director Stephen P. DeFalco - Chairman Rick Sullivan - Chief Financial Officer Steven Edelman - Director Edward J. Fiorentino - Director Peer Information Senseonics Holdings, Inc. (HLIS) Senseonics Holdings, Inc. (AZTA) Senseonics Holdings, Inc. (APYI) Senseonics Holdings, Inc. (RNVA) Senseonics Holdings, Inc. (HMSY) Senseonics Holdings, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 81727U303 SIC: 3823 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/02/26 Share - Related Items Shares Outstanding: 40.86 Most Recent Split Date: 10.00 (0.05:1) Beta: 0.63 Market Capitalization: $240.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.49 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.35 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/02/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.07 Price/Cash Flow: - Price / Sales: 8.21 EPS Growth vs. Year Ago Period: 46.25% vs. Previous Quarter: -7.50% Sales Growth vs. Year Ago Period: 89.89% vs. Previous Quarter: 21.75% ROE 12/31/25 - - 09/30/25 - -133.22 06/30/25 - -283.78 ROA 12/31/25 - - 09/30/25 - -53.40 06/30/25 - -62.85 Current Ratio 12/31/25 - - 09/30/25 - 6.23 06/30/25 - 9.58 Quick Ratio 12/31/25 - - 09/30/25 - 5.93 06/30/25 - 9.26 Operating Margin 12/31/25 - - 09/30/25 - -217.71 06/30/25 - -267.92 Net Margin 12/31/25 - - 09/30/25 - -217.71 06/30/25 - -267.92 Pre-Tax Margin 12/31/25 - - 09/30/25 - -217.62 06/30/25 - -267.82 Book Value 12/31/25 - - 09/30/25 - 1.92 06/30/25 - 2.90 Inventory Turnover 12/31/25 - - 09/30/25 - 3.46 06/30/25 - 4.97 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.45 06/30/25 - 0.37 Debt-to-Capital 12/31/25 - - 09/30/25 - 31.09 06/30/25 - 27.11

Powered by Zacks Investment Research ©